Clinical trials status

Click on the title to get more information.

Recruiting	Phase I/II multi-centered study using Heat Activated Liposomal Doxorubicin and Hyperthermia to treat patients with loco-regional recurrent breast cancer Conditions: Loco-regional breast carcinoma of the chest wall (RCW) and /or its overlying skin, with or without metastases. Occasionally RCW can be referred to by several different terms. Some of these include inflammatory breast disease, inflammatory breast cancer, chest wall breast cancer, local-regional recurrence, chest wall recurrence.
Recruiting	Phase III Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) Condition: Hepatocellular Carcinoma Interventions: Drug: ThermoDox; Drug: 5% Dextrose Solution
Recruiting	A Study of ThermoDox^™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver Conditions: Hepatocellular Carcinoma; Liver Neoplasms Intervention: Drug: ThermoDox
No Longer Recruiting	Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors Conditions: Liver Cancer; Metastatic Cancer Interventions: Drug: lyso-thermosensitive liposome doxorubicin; Procedure: chemotherapy; Procedure: radiofrequency ablation

For further information on all clinical trials please refer to www.clinicaltrials.gov.